Evolent Health Inc
Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated platform for health plan administration and value-based business infrastructure. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, anal… Read more
Evolent Health Inc (EVH) - Total Liabilities
Latest total liabilities as of September 2025: $1.61 Billion USD
Based on the latest financial reports, Evolent Health Inc (EVH) has total liabilities worth $1.61 Billion USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Evolent Health Inc - Total Liabilities Trend (2012–2024)
This chart illustrates how Evolent Health Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Evolent Health Inc Competitors by Total Liabilities
The table below lists competitors of Evolent Health Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
ToolGen Inc.
KQ:199800
|
Korea | ₩14.88 Billion |
|
Hangzhou Biotest Biotech Co Ltd
SHG:688767
|
China | CN¥134.75 Million |
|
Appen Ltd
AU:APX
|
Australia | AU$86.77 Million |
|
Tredegar Corporation
NYSE:TG
|
USA | $176.62 Million |
|
Jiusheng Electric Co. LTD
SHE:301082
|
China | CN¥2.74 Billion |
|
Hyliion Holdings Corp.
NYSE MKT:HYLN
|
USA | $12.38 Million |
|
Lanzhou Foci Pharmaceutical Co Ltd
SHE:002644
|
China | CN¥678.01 Million |
|
Logo Yazilim Sanayi ve Ticaret AS
IS:LOGO
|
Turkey | TL3.38 Billion |
Liability Composition Analysis (2012–2024)
This chart breaks down Evolent Health Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.33 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.27 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.91 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.66 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Evolent Health Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Evolent Health Inc (2012–2024)
The table below shows the annual total liabilities of Evolent Health Inc from 2012 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $1.54 Billion | -4.31% |
| 2023-12-31 | $1.61 Billion | +68.35% |
| 2022-12-31 | $957.88 Million | +31.97% |
| 2021-12-31 | $725.83 Million | -15.09% |
| 2020-12-31 | $854.84 Million | +50.24% |
| 2019-12-31 | $568.97 Million | +6.76% |
| 2018-12-31 | $532.92 Million | +100.05% |
| 2017-12-31 | $266.39 Million | -7.41% |
| 2016-12-31 | $287.73 Million | +255.50% |
| 2015-12-31 | $80.94 Million | +100.60% |
| 2014-12-31 | $40.35 Million | -43.12% |
| 2013-12-31 | $70.93 Million | +538.85% |
| 2012-12-31 | $11.10 Million | -- |